Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Prenetics Global Limited

Market Cap 349M 301M 277M 260M 488M 33B 493M 3.27B 1.28B 16.16B 1.31B 1.28B 55.92B P/E Ratio 2026 *
-13.1x
P/E Ratio 2027 * -58.9x
Enterprise Value 349M 301M 277M 260M 488M 33B 493M 3.27B 1.28B 16.16B 1.31B 1.28B 55.92B EV / Sales 2026 *
1.8x
EV / Sales 2027 * 1.14x
Free-Float
85.39%
Yield 2026 *
-
Yield 2027 * -
1 day-4.07%
1 week+3.75%
Current month-1.66%
1 month+32.93%
3 months+0.14%
6 months+41.83%
Current year+31.75%
1 week 18.12
Extreme 18.12
22.22
1 month 14
Extreme 14
22.22
Current year 14
Extreme 14
23.63
1 year 7.01
Extreme 7.01
23.63
3 years 2.85
Extreme 2.85
23.63
5 years 2.85
Extreme 2.85
131.25
10 years 2.85
Extreme 2.85
131.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 52 01/01/2014
Chief Executive Officer 47 01/01/2014
Director of Finance/CFO 41 01/01/2018
Director TitleAgeSince
Chairman 47 01/01/2014
Director/Board Member 38 -
Director/Board Member 60 13/06/2024
Date Insider Type Main position Quantity % Market Cap.
06-04Other

Director

24,004 0.1574%
05-26Free

Director

6,406 0.0420%
05-19Free

Chief Financial Officer

91,629 0.6009%
Change 5-day change 1-year change 3-year change Capi.($)
-4.07%+3.75%+196.01%+53.86% 349M
+0.56%-2.02%-34.62%-15.57% 154B
+0.22%-0.38%-7.90%-8.92% 103B
+1.63%+5.70%+64.23%+54.57% 55.68B
-0.09%+2.68%-4.77%+54.73% 54.76B
-0.49%-2.98%-15.50%-43.19% 40.1B
+1.97%+10.44% - - 31.57B
-1.53%-3.13%-9.48%-43.33% 28.64B
+0.79%+3.65%+49.35%-7.88% 23.41B
-0.76%-2.80%-14.50%-4.00% 20.6B
Average -0.32%+1.59%+24.76%+4.47% 51.27B
Weighted average by Cap. -0.00%+0.51%-5.85%-1.06%

Financials

2026 *2027 *
Net sales 194M 168M 154M 145M 272M 18.37B 274M 1.82B 712M 9B 730M 714M 31.14B 307M 264M 243M 228M 429M 28.97B 433M 2.87B 1.12B 14.19B 1.15B 1.13B 49.1B
Net income -51.66M -44.53M -40.98M -38.44M -72.22M -4.88B -72.94M -484M -189M -2.39B -194M -190M -8.27B -5.4M -4.65M -4.28M -4.02M -7.54M -510M -7.62M -50.61M -19.77M -250M -20.25M -19.82M -864M
Net Debt - -
Logo Prenetics Global Limited
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Employees
98
Date Price Change Volume
15/06/26 20.75 $ -4.07% 128,878
12/06/26 21.63 $ +4.54% 348,612
11/06/26 20.69 $ +7.48% 330,264
10/06/26 19.25 $ -8.03% 389,092
09/06/26 20.93 $ +4.65% 295,631
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
20.75USD
Average target price
31.25USD
Spread / Average Target
+50.60%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!